Canada markets closed

Design Therapeutics, Inc. (DSGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6500-0.0700 (-1.88%)
At close: 04:00PM EDT
3.7200 +0.07 (+1.92%)
After hours: 07:39PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 210.16M
Enterprise Value -68.59M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.76
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.88

Trading Information

Stock Price History

Beta (5Y Monthly) 1.83
52-Week Change 3-50.73%
S&P500 52-Week Change 324.49%
52 Week High 38.4700
52 Week Low 31.9400
50-Day Moving Average 33.3692
200-Day Moving Average 33.0693

Share Statistics

Avg Vol (3 month) 3267.62k
Avg Vol (10 day) 3170.87k
Shares Outstanding 556.49M
Implied Shares Outstanding 657.9M
Float 824.27M
% Held by Insiders 136.67%
% Held by Institutions 156.63%
Shares Short (Apr 15, 2024) 42.39M
Short Ratio (Apr 15, 2024) 46.07
Short % of Float (Apr 15, 2024) 49.40%
Short % of Shares Outstanding (Apr 15, 2024) 44.23%
Shares Short (prior month Mar 15, 2024) 42.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-15.49%
Return on Equity (ttm)-22.10%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -77.65M
Net Income Avi to Common (ttm)-66.86M
Diluted EPS (ttm)-1.1600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)281.8M
Total Cash Per Share (mrq)4.99
Total Debt (mrq)3.05M
Total Debt/Equity (mrq)1.10%
Current Ratio (mrq)29.58
Book Value Per Share (mrq)4.92

Cash Flow Statement

Operating Cash Flow (ttm)-58.56M
Levered Free Cash Flow (ttm)-34.78M